181 related articles for article (PubMed ID: 12737307)
1. Role of plasminogen activator-plasmin system in tumor angiogenesis.
Rakic JM; Maillard C; Jost M; Bajou K; Masson V; Devy L; Lambert V; Foidart JM; Noël A
Cell Mol Life Sci; 2003 Mar; 60(3):463-73. PubMed ID: 12737307
[TBL] [Abstract][Full Text] [Related]
2. The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Ismail AA; Shaker BT; Bajou K
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008762
[TBL] [Abstract][Full Text] [Related]
3. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
Pepper MS
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis.
Pepper MS; Montesano R; Mandriota SJ; Orci L; Vassalli JD
Enzyme Protein; 1996; 49(1-3):138-62. PubMed ID: 8797003
[TBL] [Abstract][Full Text] [Related]
5. Extracellular proteolysis and angiogenesis.
Pepper MS
Thromb Haemost; 2001 Jul; 86(1):346-55. PubMed ID: 11487024
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis: the key to new pathogenetic mechanisms.
Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
[TBL] [Abstract][Full Text] [Related]
7. The role of the pericellular fibrinolytic system in angiogenesis.
Fukao H; Ueshima S; Okada K; Matsuo O
Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
[No Abstract] [Full Text] [Related]
8. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
9. [Structure and functions of plasminogen/plasmin system].
Aĭsina RB; Mukhametova LI
Bioorg Khim; 2014; 40(6):642-57. PubMed ID: 25895360
[TBL] [Abstract][Full Text] [Related]
10. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies.
Bajou K; Masson V; Gerard RD; Schmitt PM; Albert V; Praus M; Lund LR; Frandsen TL; Brunner N; Dano K; Fusenig NE; Weidle U; Carmeliet G; Loskutoff D; Collen D; Carmeliet P; Foidart JM; Noël A
J Cell Biol; 2001 Feb; 152(4):777-84. PubMed ID: 11266468
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
13. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
14. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
15. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
DeClerck YA; Laug WE
Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
17. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
[TBL] [Abstract][Full Text] [Related]
18. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall.
Beers WH
Cell; 1975 Nov; 6(3):379-86. PubMed ID: 151588
[TBL] [Abstract][Full Text] [Related]
19. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators and angiogenesis.
Mignatti P; Rifkin DB
Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():33-50. PubMed ID: 8814993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
